Public Meeting on Patients Who Have Received an Organ Transplant

On September 27, 2016, FDA is conducting a public meeting on Patients Who Have Received an Organ Transplant. FDA is interested in obtaining patient input on the impact of receiving an organ transplant on daily life and patients’ views on currently available therapies to manage organ transplantation.

This website will be updated as meeting materials are developed.

Date:
September 27, 2016

Time:
9:00 a.m. - 5:00 p.m.

Location:
FDA White Oak Campus
10903 New Hampshire Ave.
Building 31, Room 1503A (Great Room)
Silver Spring, MD 20993
(Information about arrival to FDA’s White Oak campus)

Webcast Information:
Webcast

Public Docket:
Access the public docket here: Docket information

Meeting Materials:

• Federal Register Notice   

• Meeting Report (PDF - 400 KB)

• Meeting Agenda (PDF - 221KB)

• Webinar: Background on FDA and Patient-Focused Drug Development
• Meeting Slides
• Meeting Recording 1
• Meeting Recording 2
• Meeting Recording 3
• Meeting Recording 4
• Transcript

 

Related Information

• Patient-Focused Drug Development: Disease Area Meetings Planned for Fiscal Years 2013-2017
• Enhancing Benefit-Risk Assessment in Regulatory Decision-Making